James Clement, a self-described "citizen-scientist," has collected blood, skin and saliva samples from individuals aged 110-plus in 14 states and seven countries during the past six years, The New York Times reports.
Innovation
Danville, Pa.-based Geisinger is rolling out a National Precision Health Initiative as part of its strategy to expand its precision health program on the national level, and it has appointed Huntington F. Willard, PhD, as its first director.
There must be more information and data sharing amongst academics, scientists and pharmaceutical companies if the healthcare sector wants to find a cure for cancer, former Vice President Joe Biden said during a panel discussion held at the National Constitution…
With the help of a number of new partners, Microsoft thinks it can leverage its artificial intelligence and cloud technologies to address a huge problem: healthcare.
Stephen Hawking, PhD, said during an appearance Monday at the Web Summit technology conference artificial intelligence could potentially become "the worst event in the history of our civilization" if scientists and researchers do not effectively manage the technology and share…
Advertisement
The Washington University School of Medicine in St. Louis honored longtime benefactors George and Debra Couch at a dedication ceremony Oct. 6 after the couple committed $10 million to support the school's personalized medicine research initiatives.
A team of researchers in Japan demonstrated how their endoscopic system uses artificial intelligence to identify polyps during colonoscopy at the 25th United European Gastroenterology Week in Barcelona, Spain, which took place Oct. 28 to Nov. 1, USA Today reports.
In this article, Maria Serikova discusses how technology could have a positive impact on patients with mesothelioma.
Cambridge, Mass.-based Broad Institute of MIT and Harvard developed a more precise version of the gene-editing tool CRISPR-Cas9, according to the MIT Technology Review.
Companies seek to drive digital transformation of the biopharmaceutical industry by combining PAREXEL’s drug development expertise with Microsoft Azure